The U.S. Food and Drug Administration has granted Perrigo Co. final approval for hydrocodone bitartrate and homatropine methylbromide oral solution (syrup) 5 mg/1.5mg per 5 mL. Read More »
The U.S. Food and Drug Administration has approved deflazacort, a new treatment for Duchenne muscular dystrophy in patients 5 years and older. Read More »
The Lower Drug Costs through Competition Act created by the House Energy and Commerce Committee was taken off the committee’s fast track on Feb. 3 Read More »
Biotech company Amgen submitted an application to the U.S. Food and Drug Administration for Blincyto, a drug used in the treatment of lymphoblastic leukemia, to broaden its uses and treatments. Read More »
The European Commission has granted Eli Lilly & Co. marketing rights for Olumiant, a drug used to treat patients suffering with severe rheumatoid arthritis. Read More »
The U.S. Food and Drug Administration approved Amgen's Parsabiv for the treating of secondary hyperparathyroidism in adults with chronic kidney failure and is administered at dialysis locations throughout the country. Read More »
A U.S. appeals court suspended a permanent injunction on Praluent, a cholesterol management drug, allowing Regeneron Pharmaceuticals to once again manufacture, market, sell and ship the drug around the world. Read More »
PharmaSmart International, a specialist in blood pressure kiosks, announced that its machines meet new Centers for Disease Control guidelines. Read More »
Sanofi, a global leader in health care and medication distribution, has received FDA approval of Xyzal Allergy 24HR as an over-the-counter medicine. Read More »
Sanofi has received FDA approval of Xyzal Allergy 24HR, an over-the-counter option for those suffering with certain allergies. Read More »
The U.S. Food and Drug Administration released its final guidance on naming biologics and biosimilars. Read More »
ABBV-8E 12 -- a new Alzheimer’s treatment still in development -- received a fast-track designation from the U.S. Food and Drug Administration to be moved to clinical trials. Read More »
Relmada Therapeutics, a biopharmaceutical company that specializes in developing treatments for central nervous system diseases, received approval from the U.S. Food and Drug Administration to advance a new therapy to clinical trials. Read More »
The U.S. Food and Drug Administration has approved Linzess, a treatment for people suffering with chronic idiopathic constipation. Read More »
The U.S. Food and Drug Administration has given approval for the use of Narcan, an emergency treatment medication to counteract heroin overdoses, in a nasal spray form. Read More »
A new drug formulary that will allow cancer centers to access approved and investigational drugs for the use of preclinical and clinical studies in cancer treatment has been launched by the National Cancer Institute. Read More »
New consensus recommendations from the Academy of Managed Care Pharmacy ask the U.S. Food and Drug Administration to allow biopharmaceutical companies to share patient health and economic information with policy makers. Read More »
The FDA has extended the review period for Baricitnib, a new once-a-day drug for rheumatoid arthritis. Read More »
The U.S. Food and Drug Administration has approved Vantrelatm, a pain medication designed by Teva Pharmaceutical Ltd., for long-term use in time-released capsules. Read More »
The European Commission has granted Gilead Sciences Inc. marketing authorization for Vemlidy, a drug used in the treatment of people suffering from chronic Hepatitis B infections. Read More »
Alerts Sign-up
